Yale Bulletin and Calendar

October 3, 2003|Volume 32, Number 5



BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Universities should ensure global access to patented new medicines and technologies, report urges

Universities are in a unique position to draft licensing and patent strategies for the development of life-saving medicines and technologies that benefit low-and middle-income countries, according to a report by faculty and students working at the Yale Center for Interdisciplinary Research on AIDS.

The report summarizes the conclusions of a recent Yale workshop that brought together experts in public health, intellectual property management and university policy to discuss what universities can do to promote access to essential medicines and medical technologies in developing countries.

The report -- titled "Access to Essential Medicines and University Research: Building Best Practices" -- recommends that universities should not patent their discoveries in targeted developing countries. It also states that universities could negotiate clauses in their licensing agreements requiring that the products be available in low- and middle-income countries quickly, in sufficient quantities and at an appropriate cost.

The Sept. 19 issue of Science included an editorial about the report written by Dr. Michael Merson, dean and the Anna M.R. Lauder Professor of Public Health at the School of Medicine, along with recent Law School graduates Amy Kapczynski and E. Tyler Crone.

The editorial points out that in 2001 alone, universities were granted over 3,000 patents. The authors write: "They [patents] not only bring revenue, but controversy, when they ensure power over commodities that are the very currency of life itself."

The authors also point to the discussions between Yale and Bristol-Myers Squibb that resulted in the first patent concession on an AIDS drug and a 30-fold reduction in price of the patented drug in South Africa. "Such actions should not hurt universities' bottom line, diminish their ability to strike licensing deals, or discourage innovation because there is little profit at stake," Merson and his colleagues write in the editorial.

While universities and other public institutions have taken steps to make drugs more affordable and available, the editorial contends these actions are still far too rare, particularly for diseases that are not as politically relevant as AIDS.

"Where lives and health are at stake, universities should not pass the buck," notes the editorial. "University research is intended to advance the common public good. It is time that it consistently do so globally, as well as locally."


T H I SW E E K ' SS T O R I E S

F&ES to get 20% of its electricity from wind power

Program will help train future leaders in patient-oriented research

Student helped strengthen neighborhoods in her hometown . . .

Heading for 'Jeopardy!'

SOM professors' study on mutual funds gets renewed notice

Rule of law is slowly advancing in China, ambassador asserts

Yale endowment reaches record high in last fiscal year

Pulitzer Prize-winning composer joins School of Music faculty

Experts on air pollution and energy systems join the F&ES faculty

Conference to explore the future of globalization

Team learns sugars produced by cancers may help disease spread

Events mark the centennial of Russian composer

Intersection of architecture and psychoanalysis to be explored

Exhibit honors theologian who helped shape American psyche

Study: Caregivers, patients often disagree over health decisions

Universities should ensure global access patented new medicines . . .

New Yorker publisher to discuss how the magazine got its 'mojo' back

Symposium celebrates career of biochemist Donald Crothers

Homeless benefit from combination of services, says study

Robert Macnab, noted for his research on bacteria, dies

Two studies aim to help smokers quit the habit

True Blue tradition

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home